As we age, our hair grays, muscles weaken, and our immune system changes. One critical factor involves hematopoietic stem cells—the rare stem cells in the bone marrow that develop into blood and immune cells. These cells can accumulate mutations over time, increasing the risk of blood cancers and immune dysfunctions.
Now, researchers at the University of Illinois Chicago (UIC) have identified a cellular mechanism driving this aging process: the loss of a protein called platelet factor 4 (PF4). Their findings, published in the journal Blood, suggest that supplementing PF4 can rejuvenate aging blood stem cells, offering a promising therapeutic avenue for age-related disorders in the blood and immune systems.
Hematopoietic Stem Cells: The “Holy Grail” of Immunity
Hematopoietic stem cells (HSCs) are exceptionally rare but crucial. Sandra Pinho, UIC associate professor of pharmacology and regenerative medicine, calls them the “Holy Grail of the immune system.”
In a young body, HSCs produce two major groups of blood cells:
- Myeloid cells, which include certain immune cells and red blood cells that transport oxygen.
- Lymphoid cells, which include T and B cells responsible for protecting the body against infections.
With age, HSCs increasingly generate myeloid cells and fewer lymphoid cells, which weakens the immune response. This is one reason older individuals are often not used as bone marrow donors, as their stem cells are less potent.
Platelet Factor 4: The Messenger That Controls Aging
Pinho and her team discovered that platelet factor 4 plays a central role in regulating HSC aging. In young mice and humans, PF4 acts as a messenger protein, signaling HSCs—particularly those producing myeloid cells—to stop dividing excessively. This regulation prevents uncontrolled proliferation and protects the cells from accumulating mutations.
However, as the body ages, immune cells produce less PF4, allowing HSCs to proliferate unchecked. Over time, this can lead to inflammation, blood cancers, and even cardiovascular disease.
Reversing Aging in Blood Stem Cells
Remarkably, the researchers found that adding PF4 to older mice restored youthful function to their HSCs. They administered daily PF4 infusions for over a month and observed that both immune and blood cells appeared and functioned like younger cells.
Similarly, experiments with older human stem cells in the lab showed that PF4 supplementation rejuvenated their aging characteristics, demonstrating the protein’s potential across species.
Implications for Age-Related Diseases
As reported by medicalxpress, while PF4 alone cannot reverse aging in all tissues or extend overall lifespan, Pinho emphasized its potential as part of broader rejuvenation strategies. By targeting age-associated decline in blood stem cells, PF4 could mitigate immune dysfunctions and reduce the risk of blood-related diseases in older adults.
“This study provides clear evidence that certain age-related disorders can be reversed intrinsically,” Pinho said. “PF4 offers a tangible pathway to rejuvenate the blood and immune system, paving the way for new therapies in age-related conditions.”